MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Diagnosis & Differentiation

Magnetic nanoparticles-based therapy for malignant mesothelioma

Romanian Journal of Morphology and Embryology [2017] [Link] Mîndrilă I, Buteică SA, Mihaiescu DE, Burada F, Mîndrilă B, Predoi MC, Pirici I, Fudulu A, Croitoru O Abstract This work was aimed to analyze the versatility of the chick embryo chorioallantoic membrane (CAM) as in vivo model for the study of the malignant pleural mesothelioma (MPM) […]

Comments Off on Magnetic nanoparticles-based therapy for malignant mesothelioma

Targeting eukaryotic protein translation in mesothelioma

Translational Lung Cancer Research 2017 June [Link] Kratzke RA Abstract The default mechanism for protein translation in eukaryotes involves activation of the eIF4 complex at the 5′ end of mRNA. This activity is upregulated in cancers, resulting in the expression of a variety of proteins necessary for the development and maintenance of the neoplastic state. […]

Comments Off on Targeting eukaryotic protein translation in mesothelioma

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers

Discovery Medicine 2017 May [Link Rimkus T, Sirkisoon S, Harrison A, Lo HW Abstract Tumor suppressor candidate 2 (TUSC2, also known as FUS1) was identified in 2000 as a candidate tumor suppressor gene located in a region on chromosome 3p21.3 that is homozygously deleted in some lung and breast cancers. The deletion is rare in […]

Comments Off on Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.

Archives of pathology and laboratory medicine 2017 July [Epub ahead of print] [Link] Husain AN et.al. Abstract CONTEXT: – Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. OBJECTIVE: – To provide updated, practical guidelines for the pathologic diagnosis of MM. DATA SOURCES: – Pathologists involved in the International Mesothelioma Interest […]

Comments Off on Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.

A case of malignant peritoneal mesothelioma suggesting the utility of combining double-contrast radiography and endoscopy with computed tomography for diagnosis

Clinical Journal of Gastroenterology 2017 June 23 [Epub ahead of print] [Link] Saito H, Hasuda S, Nasu J, Kitaoka M, Matsushita I Abstract Abstract A 68-year-old woman presented with abdominal pain, weight loss, and vomiting. Enhanced computed tomography (CT) showed slightly increased density in the mesentery and edema of the third portion of the duodenum […]

Comments Off on A case of malignant peritoneal mesothelioma suggesting the utility of combining double-contrast radiography and endoscopy with computed tomography for diagnosis

Tumour suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma

Journal of Thoracic Oncology 2016 July [Epub ahead of print] [Link] Kao SC, Cheng YY, Williams M, Kirschner MB, Madore J, Lum T, Sarun KH, Linton A, McCaughan B, Klebe S, van Zandwijk N, Scolyer RA, Boyer MJ, Cooper WA, Reid G Abstract INTRODUCTION: The upregulation of PD-L1 is found in many cancers and contributes […]

Comments Off on Tumour suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma

Malignant Pleural Mesothelioma with Marked Lymphatic Involvement: A Report of Two Autopsy Cases

Case Reports in Oncological Medicine 2017 [Epub 2017 May 29] [Link] Ideguchi R, Ashizawa K, Akashi S, Shindo M, Minami K, Fukuda T, Irie J, Fukuda M, Uetani M Abstract We herein report two cases of malignant pleural mesothelioma with marked lymphangiosis. The patients included a 68-year-old man and a 67-year-old man who both had […]

Comments Off on Malignant Pleural Mesothelioma with Marked Lymphatic Involvement: A Report of Two Autopsy Cases

Immunohistochemical evaluation of two antibodies against PD-L1 and http://www.mesothelioma-line.com/wp-login.php?action=logout&_wpnonce=d22f9156abprognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study

European Journal of Surgical Oncology 2017 May [Epub ahead of print] [Link] Valmary-Degano S, Colpart P, Villeneuve L, Monnien F, M’Hamdi L, Lang Averous G, Capovilla M, Bibeau F, Laverriere MH, Verriele-Beurrier V, Ben Rejeb H, Dartigues P, Hommell-Fontaine J, Gilly FN, Isaac S, Mery E; French RENAPE Network Abstract BACKGROUND: Epithelioid peritoneal malignant mesothelioma […]

Comments Off on Immunohistochemical evaluation of two antibodies against PD-L1 and http://www.mesothelioma-line.com/wp-login.php?action=logout&_wpnonce=d22f9156abprognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma

Frontiers in Genetics 2017 May [Link] Kresoja-Rakic J, Sulemani M, Kirschner MB, Ronner M, Reid G, Kao S, Schwaller B, Weder W, Stahel RA, Felley-Bosco E Abstract Calretinin (CALB2) is a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM). We previously reported that calretinin expression is regulated at the mRNA level. The presence of […]

Comments Off on Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma

GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung

American Journal of Surgical Pathology 2017 June [Epub ahead of print] [Link] Berg KB, Churg A Abstract The separation of sarcomatoid and desmoplastic malignant mesotheliomas from sarcomatoid carcinomas of the lung metastatic to the pleura may be difficult, since both types of tumor can be morphologically similar and are frequently positive only for pan-keratin. GATA […]

Comments Off on GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung